Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees

被引:57
作者
Neuhausen, SL
Farnham, JM
Kort, E
Tavtigian, SV
Skolnick, MH
Cannon-Albright, LA
机构
[1] Univ Utah, Sch Med, Dept Med Informat, Salt Lake City, UT USA
[2] Intermt Hlth Care, Genet Res, Salt Lake City, UT USA
[3] Myriad Genet Inc, Salt Lake City, UT USA
关键词
D O I
10.1093/hmg/8.13.2437
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A prostate cancer susceptibility locus (HPC1) at 1q24-25 has been identified, Subsequent analysis showed that the majority of the evidence for localization was provided by families with relatively young (<65 years) average age at diagnosis, We examined evidence for linkage to this region in a set of 41 extended multi-case prostate cancer pedigrees containing 440 prostate cancer cases, Genotyping of five short tandem repeat markers in the region was performed on DNA from 1724 individuals, including 284 prostate cancer cases, In comparison with the families reported in the initial localization, the Utah pedigrees are generally much larger (average of 10.7 versus 5.1 cases) and have an older average age at diagnosis (69 versus 65 years). Two- and three-point linkage analyses were conducted using a previously reported model and provided replication for HPC1 (two-point: LOD = 1,73, P = 0.005 at D1S196; three-point: LOD = 2.06, P = 0.002 for the interval D1S196-D1S416). The youngest quartile (by median age at diagnosis) yielded a maximum LOD of 2.82, P = 0.0003 (at D1S215-D1S222), compared with a maximum LOD of 0.73, P = 0.07 for the oldest quartile pedigrees at the same locus, Further analysis with an age-dependent model, specifying higher sporadic rates for older cases, suggests that the linkage evidence may be lower than expected given the power of the resource due to a high sporadic rate in the large Utah pedigrees.
引用
收藏
页码:2437 / 2442
页数:6
相关论文
共 36 条
[1]  
*AM CANC SOC, 1998, CANC FACTS FIGURES 1
[2]  
[Anonymous], 1982, Cancer Surv
[3]   Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43 [J].
Berthon, P ;
Valeri, A ;
Cohen-Akenine, A ;
Drelon, E ;
Paiss, T ;
Wöhr, G ;
Latil, A ;
Millasseau, P ;
Mellah, I ;
Cohen, N ;
Blanché, H ;
Bellané-Chantelot, C ;
Demenais, F ;
Teillac, P ;
Le Duc, A ;
de Petriconi, R ;
Hautmann, R ;
Chumakov, I ;
Bachner, L ;
Maitland, NJ ;
Lidereau, R ;
Vogel, W ;
Fournier, G ;
Mangin, P ;
Cohen, D ;
Cussenot, O .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) :1416-1424
[4]   Comprehensive human genetic maps: Individual and sex-specific variation in recombination [J].
Broman, KW ;
Murray, JC ;
Sheffield, VC ;
White, RL ;
Weber, JL .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 63 (03) :861-869
[5]  
CANNONALBRIGHT LA, 1994, CANCER RES, V54, P2378
[6]   MENDELIAN INHERITANCE OF FAMILIAL PROSTATE-CANCER [J].
CARTER, BS ;
BEATY, TH ;
STEINBERG, GD ;
CHILDS, B ;
WALSH, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3367-3371
[7]   Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study [J].
Cooney, KA ;
McCarthy, JD ;
Lange, E ;
Huang, L ;
Miesfeldt, S ;
Montie, JE ;
Oesterling, JE ;
Sandler, HM ;
Lange, K .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (13) :955-959
[8]  
COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
[9]   Linkage analysis of chromosome 1q markers in 136 prostate cancer families [J].
Eeles, RA ;
Durocher, F ;
Edwards, S ;
Teare, D ;
Badzioch, M ;
Hamoudi, R ;
Gill, S ;
Biggs, P ;
Dearnaley, D ;
Ardern-Jones, A ;
Dowe, A ;
Shearer, R ;
McLennan, DL ;
Norman, RL ;
Ghadirian, P ;
Aprikian, A ;
Ford, D ;
Amos, C ;
King, TM ;
Labrie, F ;
Simard, J ;
Narod, SA ;
Easton, D ;
Foulkes, WD ;
Foulkes, WD .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :653-658
[10]   EPIDEMIOLOGY OF PROSTATIC-CANCER - A CASE-CONTROL STUDY [J].
FINCHAM, SM ;
HILL, GB ;
HANSON, J ;
WIJAYASINGHE, C .
PROSTATE, 1990, 17 (03) :189-206